CA - Acerus Pharmaceuticals GAAP EPS of -$1.03 revenue of $0.76M
- Acerus Pharmaceuticals press release ( OTCQB:ASPCF ): Q2 GAAP EPS of -$1.03.
- Revenue of $0.76M (+49.0% Y/Y).
- Gross profit for the second quarter of 2022 was $0.3 million compared to $0.5 million in the prior-year period.
- Cash as of June 30, 2022 was $1.3 million compared with $2.2 million as of December 31, 2021.
For further details see:
Acerus Pharmaceuticals GAAP EPS of -$1.03, revenue of $0.76M